Analysis of testosterone suppression in men receiving histrelin a novel GnRH agonist for the treatment of prostate cancer
Department of Urology, New York University Hospital, New York, New York, USA
Aug
2010 (Vol.
17, Issue
4, Pages(
5265 - 5271)
PMID: 20735905